1st Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$2,840,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Funding for Hepatitis C, HIV, oncology, and public health activities via appropriations. Advocate on drug pricing proposals, including reconciliation legislation.

LobbyistCovered position, as disclosed
TERESA BILL —
BILL BODE —
JENNIFER NIETO CAREY —
CHARLES M. CLAPTON —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Legislative and regulatory proposals to change international and domestic corporate tax law and policy.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Treasury, Dept of; SENATE

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; TRIPS Waiver; compulsory licensing and other IP issues in multiple countries.

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CHARLES M. CLAPTON —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Security Council (NSC); Patent & Trademark Office (PTO); Commerce, Dept of (DOC)

Health Issues HCR

Advocate on drug pricing proposals and proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus), including: manufacturing, clinical trials, reimbursement and coverage of Veklury (remdesivir).

LobbyistCovered position, as disclosed
TERESA BILL —
BILL BODE —
MICHAEL D BOYD —
JENNIFER NIETO CAREY —
CHARLES M. CLAPTON —
ANNA GRIFFIN —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); SENATE; Office of the Vice President of the United States; Natl Institutes of Health (NIH)

Medicare/Medicaid MMM

Advocate on drug pricing proposals, including Inflation Reduction Act. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements including changes to best price.

LobbyistCovered position, as disclosed
TERESA BILL —
BILL BODE —
MICHAEL D BOYD —
JENNIFER NIETO CAREY —
CHARLES M. CLAPTON —
ANNA GRIFFIN —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

LobbyistCovered position, as disclosed
BILL BODE —
JENNIFER NIETO CAREY —
CHARLES M. CLAPTON —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.